NCCN Guidelines® Insights: Melanoma: Cutaneous, version 2.2024: Featured Updates to the NCCN Guidelines Guidelines
| Authors: | Swetter, S. M.; Johnson, D.; Albertini, M. R.; Barker, C. A.; Bateni, S.; Baumgartner, J.; Bhatia, S.; Bichakjian, C.; Boland, G.; Chandra, S.; Chmielowski, B.; DiMaio, D.; Dronca, R.; Fields, R. C.; Fleming, M. D.; Galan, A.; Guild, S.; Hyngstrom, J.; Karakousis, G.; Kendra, K.; Kiuru, M.; Lange, J. R.; Lanning, R.; Logan, T.; Olson, D.; Olszanski, A. J.; Ott, P. A.; Ross, M. I.; Rothermel, L.; Salama, A. K.; Sharma, R.; Skitzki, J.; Smith, E.; Tsai, K.; Wuthrick, E.; Xing, Y.; McMillian, N.; Espinosa, S. |
| Title: | NCCN Guidelines® Insights: Melanoma: Cutaneous, version 2.2024: Featured Updates to the NCCN Guidelines |
| Abstract: | The NCCN Guidelines for Cutaneous Melanoma (termed Melanoma: Cutaneous) provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients. These NCCN Guidelines Insights focus on the update to neoadjuvant systemic therapy options and summarize the new clinical data evaluated by the NCCN panel for the recommended therapies in Version 2.2024 of the NCCN Guidelines for Cutaneous Melanoma. |
| Keywords: | cancer staging; neoplasm staging; melanoma; skin neoplasms; practice guideline; pathology; oncology; skin tumor; diagnosis; medical oncology; therapy; procedures; humans; human |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 22 |
| Issue: | 5 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2024-07-01 |
| Start Page: | 290 |
| End Page: | 298 |
| Language: | English |
| DOI: | 10.6004/jnccn.2024.0036 |
| PUBMED: | 39019054 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Source: Scopus |
